{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T15:47:57Z","timestamp":1749052077231,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T00:00:00Z","timestamp":1534896000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00467-018-4062-8","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T05:56:40Z","timestamp":1534917400000},"page":"81-85","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Transforming growth factor-\u03b21 in children with diabetic nephropathy"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5517-3529","authenticated-orcid":false,"given":"Happy","family":"Sawires","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama","family":"Botrous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelmegeed","family":"Aboulmagd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Madani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama","family":"Abdelhaleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,22]]},"reference":[{"key":"4062_CR1","doi-asserted-by":"publisher","first-page":"F689","DOI":"10.1152\/ajprenal.00502.2015","volume":"310","author":"AS Chang","year":"2016","unstructured":"Chang AS, Hathaway CK, Smithies O, Kakoki M (2016) Transforming growth factor-beta1 and diabetic nephropathy. Am J Physiol Renal Physiol 310:F689\u2013F696","journal-title":"Am J Physiol Renal Physiol"},{"key":"4062_CR2","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2337\/dc08-1161","volume":"32","author":"C Herder","year":"2009","unstructured":"Herder C, Brunner EJ, Rathmann W, Strassburger K, Tabak AG, Schloot NC, Witte DR (2009) Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study. Diabetes Care 32:421\u2013423","journal-title":"Diabetes Care"},{"key":"4062_CR3","first-page":"708","volume":"22","author":"N Fukuda","year":"2009","unstructured":"Fukuda N, Tahira Y, Matsuda H, Matsumoto K (2009) Transforming growth factor-beta as a treatment target in renal diseases. J Nephrol 22:708\u2013715","journal-title":"J Nephrol"},{"key":"4062_CR4","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1681\/ASN.V10122569","volume":"10","author":"V Vallon","year":"1999","unstructured":"Vallon V, Richter K, Blantz RC, Thomson S, Osswald H (1999) Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption. J Am Soc Nephrol 10:2569\u20132576","journal-title":"J Am Soc Nephrol"},{"key":"4062_CR5","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1210\/jc.2008-2534","volume":"94","author":"RB Goldberg","year":"2009","unstructured":"Goldberg RB (2009) Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 94:3171\u20133182","journal-title":"J Clin Endocrinol Metab"},{"key":"4062_CR6","doi-asserted-by":"publisher","first-page":"8015","DOI":"10.1073\/pnas.120055097","volume":"97","author":"FN Ziyadeh","year":"2000","unstructured":"Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K (2000) Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db\/db diabetic mice. Proc Natl Acad Sci U S A 97:8015\u20138020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 1","key":"4062_CR7","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1097\/01.ASN.0000093460.24823.5B","volume":"15","author":"FN Ziyadeh","year":"2004","unstructured":"Ziyadeh FN (2004) Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator. J Am Soc Nephrol 15(Suppl 1):S55\u2013S57","journal-title":"J Am Soc Nephrol"},{"key":"4062_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006583","volume":"96","author":"YC Qiao","year":"2017","unstructured":"Qiao YC, Chen YL, Pan YH, Ling W, Tian F, Zhang XX, Zhao HL (2017) Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 96:e6583","journal-title":"Medicine (Baltimore)"},{"key":"4062_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/ki.1992.14","volume":"41","author":"MV Rocco","year":"1992","unstructured":"Rocco MV, Chen Y, Goldfarb S, Ziyadeh FN (1992) Elevated glucose stimulates TGF-beta gene expression and bioactivity in proximal tubule. Kidney Int 41:107\u2013114","journal-title":"Kidney Int"},{"key":"4062_CR10","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1172\/JCI117004","volume":"93","author":"FN Ziyadeh","year":"1994","unstructured":"Ziyadeh FN, Sharma K, Ericksen M, Wolf G (1994) Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest 93:536\u2013542","journal-title":"J Clin Invest"},{"key":"4062_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/17471060701342550","volume":"5","author":"G Wolf","year":"2009","unstructured":"Wolf G, Ziyadeh FN (2009) Transforming growth factor-b and diabetic nephropathy. J organ dysfunct 5:130\u2013139","journal-title":"J organ dysfunct"},{"key":"4062_CR12","doi-asserted-by":"publisher","first-page":"854","DOI":"10.2337\/diab.46.5.854","volume":"46","author":"K Sharma","year":"1997","unstructured":"Sharma K, Ziyadeh FN, Alzahabi B, McGowan TA, Kapoor S, Kurnik BR, Kurnik PB, Weisberg LS (1997) Increased renal production of transforming growth factor-beta1 in patients with type II diabetes. Diabetes 46:854\u2013859","journal-title":"Diabetes"},{"issue":"Suppl 2","key":"4062_CR13","doi-asserted-by":"publisher","first-page":"S424","DOI":"10.1055\/s-2001-18600","volume":"109","author":"AE Raptis","year":"2001","unstructured":"Raptis AE, Viberti G (2001) Pathogenesis of diabetic nephropathy. Exp Clin Endocrinol Diabetes 109(Suppl 2):S424\u2013S437","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"4062_CR14","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1053\/S0270-9295(03)00132-3","volume":"23","author":"S Chen","year":"2003","unstructured":"Chen S, Jim B, Ziyadeh FN (2003) Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up. Semin Nephrol 23:532\u2013543","journal-title":"Semin Nephrol"},{"key":"4062_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0026-0495(00)90264-6","volume":"49","author":"B Hellmich","year":"2000","unstructured":"Hellmich B, Schellner M, Schatz H, Pfeiffer A (2000) Activation of transforming growth factor-beta1 in diabetic kidney disease. Metabolism 49:353\u2013359","journal-title":"Metabolism"},{"key":"4062_CR16","first-page":"154","volume":"68","author":"K Yoshioka","year":"1993","unstructured":"Yoshioka K, Takemura T, Murakami K, Okada M, Hino S, Miyamoto H, Maki S (1993) Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Investig 68:154\u2013163","journal-title":"Lab Investig"},{"key":"4062_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/ki.1996.65","volume":"49","author":"T Yamamoto","year":"1996","unstructured":"Yamamoto T, Noble NA, Cohen AH, Nast CC, Hishida A, Gold LI, Border WA (1996) Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int 49:461\u2013469","journal-title":"Kidney Int"},{"key":"4062_CR18","doi-asserted-by":"publisher","first-page":"5815","DOI":"10.1073\/pnas.1504777112","volume":"112","author":"CK Hathaway","year":"2015","unstructured":"Hathaway CK, Gasim AM, Grant R, Chang AS, Kim HS, Madden VJ, Bagnell CR Jr, Jennette JC, Smithies O, Kakoki M (2015) Low TGFbeta1 expression prevents and high expression exacerbates diabetic nephropathy in mice. Proc Natl Acad Sci U S A 112:5815\u20135820","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4062_CR19","doi-asserted-by":"publisher","first-page":"F85","DOI":"10.1152\/ajprenal.90642.2008","volume":"297","author":"EY Lee","year":"2009","unstructured":"Lee EY, Chung CH, Khoury CC, Yeo TK, Pyagay PE, Wang A, Chen S (2009) The monocyte chemoattractant protein-1\/CCR2 loop, inducible by TGF-beta, increases podocyte motility and albumin permeability. Am J Physiol Renal Physiol 297:F85\u2013F94","journal-title":"Am J Physiol Renal Physiol"},{"key":"4062_CR20","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1159\/000013415","volume":"18","author":"H Sato","year":"1998","unstructured":"Sato H, Iwano M, Akai Y, Kurioka H, Kubo A, Yamaguchi T, Hirata E, Kanauchi M, Dohi K (1998) Increased excretion of urinary transforming growth factor beta 1 in patients with diabetic nephropathy. Am J Nephrol 18:490\u2013494","journal-title":"Am J Nephrol"},{"key":"4062_CR21","doi-asserted-by":"publisher","first-page":"664","DOI":"10.2337\/diacare.23.5.664","volume":"23","author":"E Korpinen","year":"2000","unstructured":"Korpinen E, Teppo AM, Hukkanen L, Akerblom HK, Gronhagen-Riska C, Vaarala O (2000) Urinary transforming growth factor-beta1 and alpha1-microglobulin in children and adolescents with type 1 diabetes. Diabetes Care 23:664\u2013668","journal-title":"Diabetes Care"},{"key":"4062_CR22","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/j.1464-5491.2004.01242.x","volume":"21","author":"L Flores","year":"2004","unstructured":"Flores L, Naf S, Hernaez R, Conget I, Gomis R, Esmatjes E (2004) Transforming growth factor beta at clinical onset of type 1 diabetes mellitus. A pilot study. Diabet Med 21:818\u2013822","journal-title":"Diabet Med"},{"key":"4062_CR23","volume":"2013","author":"K Zorena","year":"2013","unstructured":"Zorena K, Raczynska D, Wisniewski P, Malinowska E, Mysliwiec M, Raczynska K, Rachon D (2013) Relationship between serum transforming growth factor beta 1 concentrations and the duration of type 1 diabetes mellitus in children and adolescents. Mediat Inflamm 2013:849457","journal-title":"Mediat Inflamm"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-018-4062-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-4062-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-4062-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T23:13:13Z","timestamp":1661814793000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-018-4062-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,22]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["4062"],"URL":"https:\/\/doi.org\/10.1007\/s00467-018-4062-8","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"type":"print","value":"0931-041X"},{"type":"electronic","value":"1432-198X"}],"subject":[],"published":{"date-parts":[[2018,8,22]]},"assertion":[{"value":"11 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the local ethics committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"An informed consent was obtained from patients\u2019 caregivers. The research does not include animals and there were no clinical trials on human subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights and informed consent"}}]}}